Board of Directors

J. Alex Martin

Chairman of the Board

A 40-year, veteran corporate executive of the healthcare and medical device industries, Mr. Martin brings an accomplished track record for growing corporate revenue and successfully transforming global businesses. Mr. Martin was the President and CEO of Coherex Medical, where he led the company to a successful exit with Biosense Webster (a Johnson and Johnson company), in November 2015. Prior to Coherex, Mr. Martin was the President and CEO of WorldHeart Corporation, where he led the company to a successful exit with HeartWare in August 2012. Previously, Mr. Martin has held senior leadership roles with Edwards Lifesciences, Cordis Corporation, a Johnson & Johnson Company, and SonaMed Corporation. Mr. Martin holds a bachelor’s degree from the University of Kentucky.

Michael Fulton, M.D.

Dr. Fulton is currently a Managing Director at Hopen Life Science Ventures, a venture capital firm. Dr. Fulton has over 20 years’ experience in the life sciences space, and prior to joining Hopen, Mike served in the roles of founder, director, and CEO at startup medical device and services companies, including Lanx, Inc., the second largest private company in the $7B spinal implant market. Mike is an inventor of multiple neurosurgical and spinal devices with over 50 issued and pending U.S. and international patents. He received his B.A. from Northwestern University, his M.D. from Cornell University Medical College, and completed two years of neurosurgery residency at the Cleveland Clinic.

Avi Kometz, M.D.

Dr. Kometz is a Partner on the Private Transactions team joining Deerfield Capital Management in 2014. Prior to joining Deerfield, Dr. Kometz was a partner at Ascent Biomedical Ventures, where he led investment efforts in biotechnology, pharmaceuticals, medical devices and healthcare information technology. Dr. Kometz has more than 20 years experience in the healthcare industry, including pharmaceutical Corporate Development and pipeline valuation for PediaMed Pharmaceuticals, Inc. and McKinsey and Company. Dr. Kometz worked for several multinational pharmaceutical companies on projects including developing a nutraceutical strategy, assessing technical, clinical and regulatory development risks for pharmaceutical products, augmenting pipeline product valuation methodologies, and organizational change and cost-cutting efforts. Dr. Kometz’s educational background includes medical degrees from the University of Witwatersrand, School of Medicine in Johannesburg, South Africa.

Nicole Walker

Ms. Walker joined Baird Capital’s Venture Capital team in 2013 and focuses on healthcare investments. Ms. Walker is a current member of the Board of Directors at Palyon Medical Corporation, NeuMoDx, and Molecular Imaging. Prior to joining Baird Capital, she managed the strategic planning, market development, and product portfolio initiatives for multiple brands in discrete and continuous blood glucose monitoring for Abbott Ventures. Previously, Ms. Walker was with ONSET Ventures, specializing in seed and early-stage healthcare technology investments. At Guidant Corporation, Ms. Walker held roles in operations, product design & development, engineering management, and marketing. Ms. Walker’s educational background includes a BS in Mechanical Engineering from Stanford University, an MBA from the Kellogg School of Management and an MEM (Masters of Engineering Management) from the McCormick School of Engineering at Northwestern University.

David Chung

Mr. Chung has over twenty-five years of hospital-focused, global medical device and pharmaceutical sales and marketing leadership, most recently serving in the role as Chief Commercial Officer for AcelRx Pharmaceuticals. Prior to AcelRx, Mr. Chung served as Chief Commercial Officer for Conceptus (Bayer), where he oversaw the strategic and day-to-day leadership for a 150-member global sales and marketing team. Prior to Conceptus, Mr. Chung served as President and CEO of Mitralis, an early-stage mitral valve repair company. Mr. Chung has previously held roles of Vice President North America Sales and Marketing, and Global Vice President, Commercial Operations, for the Heart Valve Therapy business at Edwards Lifesciences. Mr. Chung began his career at Pfizer for both medical device and pharmaceutical sales. Mr. Chung’s educational background includes an engineering degree from the United States Military Academy, West Point, N.Y.